Overexpression of Nrf2 and the vitagene pathways play intrinsic roles in boosting the tumorigenic cascade, as well as prospective therapeutic interventions via inhibitors that stop the proliferation and chemoresistance of brain cancer cells by enhancing apoptosis [107]. This evidence concerns the gene NFE2L2 and brain cancer.